Since first introducing a blood type testing kit in Korea in 1972, GCMS went on to develop the first-ever AIDS diagnostic kit in Korea, releasing it in 1987, and following this up with the launch of a diagnostic agent for hemorrhagic fever with renal syndrome in 1990.
The company today produces over 250 types of diagnostic agents for nearly 40 diseases. It is also researching and developing advanced molecular diagnostic technology to produce more accurate and timely diagnosis of various threats to human health, including HIV and hepatitis.
Innovating health solutions based on personalized nutrition therapy
Address7F Dodam Building (Unit B), 246 Hwangsaeul-ro, Bundang-gu, Seongnam, Gyeonggi-do (7F Dodam Building (Unit B), 9-3 Sunae-dong, Bundang-gu, Seongnam, Gyeonggi-do)
ContactTel. +82-1577-5560 / Fax: +82-31-629-8601
GC Wellbeing is the result of a merger between GCJBP, which specialized in placenta-derived pharmaceuticals, GCHS, which produced natural drugs and materials, and the WB Division of GC Biopharma.
GC Wellbeing today researches, develops, and produces a wide variety of personalized nutrition therapy solutions and health supplements, strengthening its position as a new leader in the personalized healthcare solutions market. The company is also researching and developing a broad array of natural drugs and health supplements.
From blood glucose meter for human body to glycated hemoglobin meter (HbA1c) for hospital, Furthermore, blood sugar for animals and lactic acid POCT can be obtained with a single drop of blood. A health-leading company
Address16, Jeongja 1-gil, Seonggeo-eup, Seobuk-gu, Cheonan-si, Chungcheongnam-do, 31045, Republic of Korea
GREEN CROSS MEDIS corp. was established in 2005 as a specialized POCT (point-of-care test) company based on IT and Bio convergence technology in the mobile health care and in vitro diagnostic business under the motto of "Bio -IT technology for human, We find the answers from a drop of blood.".
We are developing a multi-measurement system for point-of-care diagnosis that combines glycated hemoglobin(HbA1c), inflammatory markers(CRP), kidney disease(U-albumin), and blood coagulation (D-Dimer) markers for point-of-care diagnosis along with accurate and high-quality blood glucose measurement system products.
GC LabCell, which came out of a merger between the cell therapy division of GC Biopharma and the cord blood storage division of GC Labs, focuses on its strategic tasks of researching and developing Natural Killer(NK) cell-based immunotherapy agents and stem cell-based treatments for rare diseases.
The company plans to expand its business into development of more diverse stem cell-based treatments and a comprehensive range of healthcare services for the global market.
GC Genome specializes in research, development, and production of diagnostic techniques, including those for pre-pregnancy genetic analysis, cancer gene analysis, and individual responses to drugs.
With the acquisition of a next-generation genetic sequencing analyzer and a large-capacity genetic analyzer, the company will continue to research and develop cutting-edge genetic diagnostic techniques and personalized treatment solutions.
This subsidiary was established to focus on distribution of its parent company’s (GC China) pharmaceutical products on the Chinese market.
GC China Pharm is expected to contribute to GC China’s growth through its sales activities. It distributes products via eight dealerships across China today, including the main one in Shanghai.
A biotech company accelerating the clinical development of innovative vaccine products
Address1616 Eastlake Avenue East Suite 290, Seattle WA 98102
Curevo is a Seattle-based biotech company that is currently conducting clinical trials on the next-generation vaccine against varicella zoster (CRV101).
Curevo is transforming itself into a future leader of the global vaccine market, conducting clinical trials on a wide range of innovative vaccines against a variety of infectious and contagious diseases.
Through partnership with the world-class Infectious Disease Research Institute (IDRI), Curevo continues to augment its expertise.
GC Biopharma launched the Mogam Institute for Biomedical Research, its nonprofit research wing, in 1984 with the proceeds it earned from Hepavax, the company’s hepatitis-B vaccine (the third successful one in the country).
The institute is tasked with promoting advances in biomedical technology, reinvesting its profits in fostering a stable and conducive environment for research. It is also the first-ever nonprofit research corporation established with the Ministry of Science and Technology (currently the Ministry of Science and ICT) in Korea.
We are conducting research to develop new drugs using artificial intelligence.
GC Labs, founded in 1982 as a corporation specializing in clinical research and trials, has partnered with numerous leading clinical trial institutes around the world. Its main focus is on enabling GC Biopharma to achieve open innovation and distinction by adopting the latest-technology equipment, developing a highly qualified workforce, and conducting sophisticated tests with university hospitals and other advanced medical institutions.
GC Labs, housed in a state-of-the-art clinical test center with a total floor area of over 1,200 square meters—the first-ever building to be built exclusively for clinical trial purposes—continues to undertake all its tests in environments of strict control and safety. It was also the first corporate research affiliate in Korea to be awarded ISO 9001 Quality Management System and ISO 14001 Environmental Management System certification simultaneously in 2008.
The cutting-edge all-automated systems at GC Labs support the conduct and completion of over 4,000 types of tests in a precise and timely manner, around the clock. GC Labs handles the largest number of special tests in Korea.
GC i-Med was established in 1991 with the mission of ushering in health for all through advanced diagnostic techniques and functional medicine.
The combination of cutting-edge IT systems and a care program promoting efficient health management has given birth to personalized diagnostic and healthcare services that cater to clients’ health needs throughout all stages of life.
With the help of state-of-the-art testing systems and equipment, its talented, experienced medical staff provides a wide range of medical services.
The diagnostic system based on partnerships with leading medical institutions in Korea and the U-Healthcare Program that provides thorough follow-up healthcare services make GC i-Med a topnotch center for diagnostics and functional medicine capable of providing optimal health solutions for all clients.
GC Invacfarm boasts a quarantine and containment system of the highest quality in Korea. It operates a chicken farm and fertile egg production system for vaccine production according to the most rigorous quality assurance standards.
The company contributes to the growth and advancement of GCFLU as a reliable provider of quality fertilized eggs.
GC녹십자는 이메일 수집을 거부합니다
본 웹사이트에 게시된 이메일 주소가 전자우편 수집 프로그램이나 그 밖의 기술적 장치를 이용하여 무단으로 이메일 주소를 수집하는 행위를 거부하며, 이를 위반시 정보통신망 이용촉진 및 정보보호 등에 관한 법률에 의해 형사처벌됨을 유념하시기 바랍니다